|
MechanismD1 receptor antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date19 Nov 1946 |
100 Clinical Results associated with EDISON THERAPEUTICS LLC
0 Patents (Medical) associated with EDISON THERAPEUTICS LLC
100 Deals associated with EDISON THERAPEUTICS LLC
100 Translational Medicine associated with EDISON THERAPEUTICS LLC